Factors Affecting Virological Failure in Children Receiving First-Line Antiretroviral Therapy in Ethiopian Healthcare Facilities: A Retrospective Analysis

References

• Approach PH, On CG. Guidelines HIV prevention, testing, treatment, service delivery and monitoring; 2021.
   Google Scholar
• World Health Organization. Global HIV, hepatitis and STIs programmes. HIV data Stat Geneva WHO; 2020.;
   Google Scholar
• World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. World Health Organization; 2015.
   Google Scholar
• Pennings PS. HIV drug resistance: problems and perspectives. Infect Dis Rep. 2013;5(Suppl 1):e5. doi:10.4081/idr.2013.s1.e5
   PubMedGoogle Scholar
• Arpadi SM, Shiau S, De Gusmao EP, Violari A. Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities. J Int AIDS Soc. 2017;20(S7):e25001. doi:10.1002/jia2.25001
   PubMedGoogle Scholar
• Bulage L, Ssewanyana I, Nankabirwa V, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. BMC Infect Dis. 2017;17(1):1–11. doi:10.1186/s12879-017-2428-3
   PubMed Web of Science ®Google Scholar
• Getaneh Y, Yizengaw A, Likie A, et al. Rate and predictors of treatment failure among pediatric population taking highly active antiretroviral therapy in Ethiopia. medRxiv. 2019;2:19005538.
   Google Scholar
• Jiao K, Wang C, Liao M, et al. A differentiated digital intervention to improve antiretroviral therapy adherence among men who have sex with men living with HIV in China: a randomized controlled trial. BMC Med. 2022;20(1):1–15. doi:10.1186/s12916-022-02538-3
   PubMed Web of Science ®Google Scholar
• Zenebe E, Washo A, Addis Gesese A, Karwowski J. Time to first-line antiretroviral treatment failure and its predictors among HIV-positive children in shashemene town health facilities, Oromia Region, Ethiopia, 2019. Sci World J. 2021;2021:8868479. doi:10.1155/2021/8868479
   Google Scholar
• Ethiopia FM. National consolidated guidelines for comprehensive HIV prevention, care and; 2018.
   Google Scholar
• Kadima J, Patterson E, Mburu M, et al. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya. PLoS One. 2018;13(11):e0200242. doi:10.1371/journal.pone.0200242
   PubMed Web of Science ®Google Scholar
• Shumetie A, Moges NA, Teshome M, Gedif G. Determinants of virological failure among HIV-infected children on first-line antiretroviral therapy in West Gojjam Zone, Amhara Region, Ethiopia. HIV AIDS Res Palliat Care. 2021;13:1035–1044. doi:10.2147/HIV.S334067
   Web of Science ®Google Scholar
• Zoufaly A, Fillekes Q, Hammerl R, et al. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study. Antivir Ther. 2013;18(5):681–690. doi:10.3851/IMP2562
   PubMed Web of Science ®Google Scholar
• Afrane AKA, Goka BQ, Renner L, et al. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study. BMC Infect Dis. 2021;21(1):1–11. doi:10.1186/s12879-021-06459-z
   PubMed Web of Science ®Google Scholar
• Jobanputra K, Parker LA, Azih C, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015;10(2):e0116144. doi:10.1371/journal.pone.0116144
   PubMed Web of Science ®Google Scholar
• Gelaw B, Mulatu G, Tesfa G, Marew C, Chekole B, Alebel A. Magnitude and associated factors of virological failure among children on ART in Bahir Dar Town public health facilities, Northwest Ethiopia: a facility based cross-sectional study. Ital J Pediatr. 2021;47(1):1–9. doi:10.1186/s13052-021-01030-7
   PubMed Web of Science ®Google Scholar
• Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12(1):1–8. doi:10.1186/1471-2334-12-197
   PubMed Web of Science ®Google Scholar
• Abdullahi IJ, Deybasso HA, Adlo AM. Determinants of virological failure among patients on first-line antiretroviral therapy in central Oromia, Ethiopia: a case–control study. HIV AIDS Res Palliat Care. 2020;12:931–939. doi:10.2147/HIV.S281672
   Web of Science ®Google Scholar
• Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):1–7. doi:10.1186/s12879-019-3924-4
   PubMed Web of Science ®Google Scholar
• Bitwale NZ, Mnzava DP, Kimaro FD, Jacob T, Mpondo BCT, Jumanne S. Prevalence and factors associated with virological treatment failure among children and adolescents on antiretroviral therapy attending HIV/AIDS care and treatment clinics in Dodoma Municipality, Central Tanzania. J Pediatric Infect Dis Soc. 2021;10(2):131–140. doi:10.1093/jpids/piaa030
   PubMed Web of Science ®Google Scholar
• Barry O, Powell J, Renner L, et al. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana. BMC Infect Dis. 2013;13(1):1–10. doi:10.1186/1471-2334-13-476
   PubMedGoogle Scholar
• Cissé A-M, Laborde-Balen G, Kébé-Fall K, et al. High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal. BMC Pediatr. 2019;19(1):1–8. doi:10.1186/s12887-019-1420-z
   PubMedGoogle Scholar
• Rangarajan S, Colby DJ, Bui DD, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J virus Erad. 2016;2(2):94–101. doi:10.1016/S2055-6640(20)30466-0
   PubMed Web of Science ®Google Scholar
• Crawford KW, Wakabi S, Magala F, Kibuuka H, Liu M, Hamm TE. Evaluation of treatment outcomes for patients on first‐line regimens in US President’s Emergency Plan for AIDS Relief (PEPFAR) clinics in U ganda: predictors of virological and immunological response from RV 288 analyses. HIV Med. 2015;16(2):95–104. doi:10.1111/hiv.12177
   PubMed Web of Science ®Google Scholar
• García F, de Lazzari E, Plana M, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. JAIDS J Acquir Immune Defic Syndr. 2004;36(2):702–713. doi:10.1097/00126334-200406010-00007
   PubMed Web of Science ®Google Scholar